1 completed, 1 withdrawn. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Metastatic Cancer Lung: new trials by email Literature Review of Metastatic Cancer Lung trials Research Report on Metastatic Cancer Lung
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures Atezolizumab 1200 mg IV, Tiragolumab 600 mg IV - Metastatic Cancer Lung, Advanced Lung Cancer | Phase 2 | Withdrawn | Gustave Roussy, Cancer Campus, Grand Paris | 2025-01-30 | 2026-03-23 | |
| [18F]-AZAFOL AS POSITRON EMISSION TOMOGRAPHY (PET) TRACER in FR Positive Cancer Imaging [18F]-AzaFol, folarell - Metastatic Cancer Lung, Metastatic Ovarian Cancer | Phase 1 | Completed | University of Lausanne Hospitals | 15 | 2017-04-01 | 2020-02-28 |
Lung Neoplasms (2) · Ovarian Neoplasms (1)
Lung Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Adnexal Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1)
Folic Acid (1) · Tiragolumab (1) · atezolizumab (1)
Gustave Roussy, Cancer Campus, Grand Paris (1) · University of Lausanne Hospitals (1)
Switzerland (1)
John Prior, Prof (1)
2023 (1)